{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:04:14Z","timestamp":1791644654107,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human papillomavirus (HPV) is the most common sexually transmitted pathogen both in men and women. Accumulating epidemiological evidence supports a strong association between HPV infection and cancer of the cervix, vulva, vagina, anus, and penis. Currently, data on the HPV prevalence and genotyping is lacking in Northern Cyprus, a region in which HPV vaccination is not freely accessible via the national immunization program. The aim of this study was to evaluate the HPV type-specific prevalence in women with and without cytological abnormalities living in Northern Cyprus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 885 women who presented to the Department of Gynecology and Obstetrics Clinic between January 2011 and December 2022 were included in the study. Samples were collected for cytology. Cervical specimens were investigated for the presence of HPV-DNA and genotyping of HPV was performed using real-time polymerase chain reaction (rtPCR). Cytological examination was interpreted according to the Bethesda system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among all patients, overall high-risk HPV DNA prevalence was 44.3%. HPV-16 and HPV-18 positivity was found in 10.4% and 3.7% of women respectively, while other high-risk HPV (OHR-HPV) was the most frequent type of HPV (30.2%). The highest frequency of HPV infection was observed in the 30\u201355 age group (51.0%), followed by the &lt;\u200930 age group (45.7%). Co-infection with two or more HPV types was observed in 17.0% of all positive samples, in which the prevalence of HPV-16\u2009+\u2009HPV-18 was 2.3%, HPV-16\u2009+\u2009OHR-HPV and HPV-18\u2009+\u2009OHR-HPV was 12.0% and 5.1%, respectively. Among the screened patients, 37.5% had abnormal and 62.5% had normal cytology results. HR-HPV positivity was 65.7% and 34.0% in patients with abnormal and normal cytology. The highest incidence of HRC-HPV was OHR-HPV types (44.7%) in positive cytology cases. Among women with a cytology result of ASCUS, L-SIL, H-SIL and unspecified dysplasia, 52.1%, 67.6%, 97.5% and 75.6% were respectively infected with HR-HPV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The present study provides the latest epidemiological data related to HPV prevalence and genotype distribution among women living in Northern Cyprus. Considering the unavailability of free vaccination in the community, it is imperative to implement local HPV screening programs and provide guidelines on HPV prevention and measures during early school education.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02451-8","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T18:01:26Z","timestamp":1685815286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence and genotype screening of human papillomavirus among women attending a private hospital in Northern Cyprus: an 11-year retrospective study"],"prefix":"10.1186","volume":"23","author":[{"given":"Buket","family":"Baddal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makbule Naz","family":"Oktay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Bostanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufit Cemal","family":"Yenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,3]]},"reference":[{"issue":"3","key":"2451_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/CAAC.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/CAAC.21660.","journal-title":"Cancer J Clin"},{"key":"2451_CR2","doi-asserted-by":"publisher","unstructured":"Petca A, Borislavschi A, Zvanca M, Petca R-C, Sandru F, Dumitrascu M. Non-sexual HPV transmission and role of vaccination for a better future (review). Experimental and Therapeutic Medicine. 2020;20(6). https:\/\/doi.org\/10.3892\/etm.2020.9316.","DOI":"10.3892\/etm.2020.9316"},{"issue":"4","key":"2451_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/IJC.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664\u201370. https:\/\/doi.org\/10.1002\/IJC.30716.","journal-title":"Int J Cancer"},{"key":"2451_CR4","doi-asserted-by":"publisher","unstructured":"Arbyn M, Tommasino M, Depuydt C, Dillner J. Are 20 human papillomavirus types causing cervical cancer? J Pathol (Vol. 2014;234(4). https:\/\/doi.org\/10.1002\/path.4424.","DOI":"10.1002\/path.4424"},{"key":"2451_CR5","doi-asserted-by":"publisher","unstructured":"Wang X, Huang X, Zhang Y. (2018). Involvement of human papillomaviruses in cervical cancer. In Frontiers in Microbiology (Vol.\u00a09, Issue NOV). https:\/\/doi.org\/10.3389\/fmicb.2018.02896.","DOI":"10.3389\/fmicb.2018.02896"},{"key":"2451_CR6","doi-asserted-by":"publisher","unstructured":"Chow LT, Broker TR. Human papillomavirus infections: warts or cancer? Cold Spring Harb Perspect Biol. 2013;5(7). https:\/\/doi.org\/10.1101\/cshperspect.a012997.","DOI":"10.1101\/cshperspect.a012997"},{"key":"2451_CR7","doi-asserted-by":"publisher","unstructured":"Chelimo C, Wouldes TA, Cameron LD, Elwood JM. (2013) Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. Journal of Infection, 66 (2013); 207\u2013217. oi: https:\/\/doi.org\/10.1016\/j.jinf.2012.10.024.","DOI":"10.1016\/j.jinf.2012.10.024"},{"key":"2451_CR8","doi-asserted-by":"publisher","first-page":"914516","DOI":"10.3389\/fmicb.2022.914516","volume":"13","author":"D Yang","year":"2022","unstructured":"Yang D, Zhang J, Cui X, Ma J, et al. Risk factors associated with human papillomavirus infection, cervical cancer, and precancerous lesions in large-scale population screening. Front Microbiol. 2022;13:914516. https:\/\/doi.org\/10.3389\/fmicb.2022.914516.","journal-title":"Front Microbiol"},{"issue":"3","key":"2451_CR9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/vaccines11030698","volume":"11","author":"A Giannini","year":"2023","unstructured":"Giannini A, Di Donato V, Sopracordevole F, Ciavattini A, et al. Outcomes of high-grade cervical dysplasia with positive margins and HPV persistence after cervical conization. Vaccines. 2023;11(3):698. https:\/\/doi.org\/10.3390\/vaccines11030698.","journal-title":"Vaccines"},{"key":"2451_CR10","doi-asserted-by":"publisher","unstructured":"Lin S, Gao K, Gu S, You L, Qian S, Tang M, Wang J, Chen K, Jin M. Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years. Cancer. 2021;127(21). https:\/\/doi.org\/10.1002\/cncr.33795.","DOI":"10.1002\/cncr.33795"},{"key":"2451_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3332\/ecancer.2019.978","volume":"13","author":"A Christodoulou","year":"2019","unstructured":"Christodoulou A, Ajzajian J, Su D, Wang H, Roupa Z, Farazi PA. Awareness of human papilloma virus and cervical cancer prevention among cypriot female healthcare workers. Ecancermedicalscience. 2019;13:978. https:\/\/doi.org\/10.3332\/ecancer.2019.978.","journal-title":"Ecancermedicalscience"},{"key":"2451_CR12","doi-asserted-by":"publisher","unstructured":"Cheng L, Wang Y, Du J. Human papillomavirus vaccines: an updated review. Vaccines. 2020;8(3). https:\/\/doi.org\/10.3390\/vaccines8030391.","DOI":"10.3390\/vaccines8030391"},{"key":"2451_CR13","unstructured":"KKTC Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Temel Sa\u011fl\u0131k Hizmetleri Dairesi. (2020). Eri\u015fkin A\u015f\u0131lama Rehberi. https:\/\/tshd.gov.ct.tr\/eriskin-asilama-rehberi\/ Date of accession: 29\/04\/2023."},{"key":"2451_CR14","doi-asserted-by":"publisher","unstructured":"Krashias G, Koptides D, Christodoulou C. HPV prevalence and type distribution in cypriot women with cervical cytological abnormalities. BMC Infect Dis. 2017;17(1). https:\/\/doi.org\/10.1186\/s12879-017-2439-0.","DOI":"10.1186\/s12879-017-2439-0"},{"issue":"1","key":"2451_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12985-023-01959-7","volume":"20","author":"W Zhang","year":"2023","unstructured":"Zhang W, Guo N, Li B, Shang E, Wang J, Zhang M, Yang X. Prevalence and genotype distribution of human papillomavirus infections in Beijing, China between 2016 and 2020. Virol J. 2023;20(1):11. https:\/\/doi.org\/10.1186\/s12985-023-01959-7.","journal-title":"Virol J"},{"issue":"10","key":"2451_CR16","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1002\/jmv.27921","volume":"94","author":"A Altay-Kocak","year":"2022","unstructured":"Altay-Kocak A, Kazanci F, Dogu\u2010Tok C, Onan A, Erdem O, Ozkan S, Bozdayi G. The prevalence and distribution of human papillomavirus in 4267 turkish women with or without cervical lesions: a hospital\u2010based study. J Med Virol. 2022;94(10):5026\u201332. https:\/\/doi.org\/10.1002\/jmv.27921.","journal-title":"J Med Virol"},{"key":"2451_CR17","doi-asserted-by":"publisher","unstructured":"Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C, Wang R, Wang J, Qi D. HPV prevalence and genotype distribution among women in Shandong Province, China: analysis of 94,489 HPV genotyping results from Shandong\u2019s largest independent pathology laboratory. PLoS ONE. 2019;14(1). https:\/\/doi.org\/10.1371\/journal.pone.0210311.","DOI":"10.1371\/journal.pone.0210311"},{"key":"2451_CR18","doi-asserted-by":"publisher","unstructured":"Rahmat F, Kuan JY, Hajiman Z, Shakrin NNSM, Roos NAC, Mustapa M, Ahmad A. Human papillomavirus (HPV) prevalence and type distribution in Urban Areas of Malaysia. Asian Pac J Cancer Prev. 2021;22(9). https:\/\/doi.org\/10.31557\/APJCP.2021.22.9.2969.","DOI":"10.31557\/APJCP.2021.22.9.2969"},{"key":"2451_CR19","doi-asserted-by":"publisher","unstructured":"Colpani V, Falcetta FS, Bidinotto AB, Kops NL, Falavigna M, Hammes LS, Benzaken AS, Maranh\u00e3o AGK, Domingues CMAS, Wendland EM. Prevalence of human papillomavirus (HPV) in Brazil: a systematic review and meta-analysis. PLoS ONE. 2020;15(2). https:\/\/doi.org\/10.1371\/journal.pone.0229154.","DOI":"10.1371\/journal.pone.0229154"},{"key":"2451_CR20","doi-asserted-by":"publisher","unstructured":"Muresu N, Sotgiu G, Marras S, Gentili D, Sechi I, Cossu A, Dettori A, Pietri RE, Paoni L, Ghi ME, Bagella MP, Marrazzu A, Cossu A, Genovesi A, Piana A, Saderi L. Cervical screening in North Sardinia (Italy): genotype distribution and prevalence of HPV among women with ASC-US Cytology. Int J Environ Res Public Health. 2022;19(2). https:\/\/doi.org\/10.3390\/ijerph19020693.","DOI":"10.3390\/ijerph19020693"},{"key":"2451_CR21","doi-asserted-by":"publisher","unstructured":"Shaltout MF, Sallam HN, AbouSeeda M, Moiety F, Hemeda H, Ibrahim A, Sherbini MEL, Rady H, Gopala K, DeAntonio R. Prevalence and type distribution of human papillomavirus among women older than 18 years in Egypt: a multicenter, observational study. Int J Infect Dis. 2014;29. https:\/\/doi.org\/10.1016\/j.ijid.2014.07.029.","DOI":"10.1016\/j.ijid.2014.07.029"},{"key":"2451_CR22","doi-asserted-by":"publisher","unstructured":"Chaturvedi AK, Katki HA, Hildesheim A, Rodr\u00edguez AC, Quint W, Schiffman M, van Doorn LJ, Porras C, Wacholder S, Gonzalez P, Sherman ME, Herrero R. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis. 2011;203(7). https:\/\/doi.org\/10.1093\/infdis\/jiq139.","DOI":"10.1093\/infdis\/jiq139"},{"issue":"12","key":"2451_CR23","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.22034\/APJCP.2017.18.12.3373","volume":"18","author":"S Ahmadi","year":"2017","unstructured":"Ahmadi S, Goudarzi H, Jalilvand A, Esmaeilzadeh A. Human papilloma virus genotype distribution in cervical lesions in Zanjan, Iran. Asian Pac J Cancer Prevention: APJCP. 2017;18(12):3373\u20137. https:\/\/doi.org\/10.22034\/APJCP.2017.18.12.3373.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"key":"2451_CR24","doi-asserted-by":"publisher","first-page":"12583","DOI":"10.2147\/CMAR.S269050","volume":"12","author":"L Song","year":"2020","unstructured":"Song L, Lyu Y, Ding L, Li X, Gao W, Wang M, Hao M, Wang Z, Wang J. Prevalence and genotype distribution of high-risk human papillomavirus infection in women with abnormal cervical cytology: a Population-Based study in Shanxi Province, China. Cancer Manag Res. 2020;12:12583\u201391. https:\/\/doi.org\/10.2147\/CMAR.S269050.","journal-title":"Cancer Manag Res"},{"issue":"10","key":"2451_CR25","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","volume":"131","author":"P Guan","year":"2012","unstructured":"Guan P, Howell-Jones R, Li N, Bruni L, de Sanjos\u00e9 S, Franceschi S, Clifford GM. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349\u201359. https:\/\/doi.org\/10.1002\/ijc.27485.","journal-title":"Int J Cancer"},{"key":"2451_CR26","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3332\/ecancer.2019.952","volume":"13","author":"M Ngoma","year":"2019","unstructured":"Ngoma M, Autier P. Cancer prevention: cervical cancer. Ecancermedicalscience. 2019;13:952. https:\/\/doi.org\/10.3332\/ecancer.2019.952.","journal-title":"Ecancermedicalscience"},{"issue":"4","key":"2451_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/vaccines10040579","volume":"10","author":"G Bogani","year":"2022","unstructured":"Bogani G, Lalli L, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T, et al. Development of a nomogram predicting the risk of persistence\/recurrence of cervical dysplasia. Vaccines (Basel). 2022;10(4):579. https:\/\/doi.org\/10.3390\/vaccines10040579.","journal-title":"Vaccines (Basel)"},{"issue":"10316","key":"2451_CR28","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","volume":"398","author":"M Falcaro","year":"2021","unstructured":"Falcaro M, Casta\u00f1on A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, Elliss-Brookes L, Sasieni P. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. The Lancet. 2021;398(10316):2084\u201392. https:\/\/doi.org\/10.1016\/S0140-6736(21)02178-4.","journal-title":"The Lancet"},{"key":"2451_CR29","doi-asserted-by":"publisher","first-page":"106960","DOI":"10.1016\/j.ypmed.2022.106960","volume":"156","author":"A Vorsters","year":"2022","unstructured":"Vorsters A, Bosch FX, Poljak M, Waheed D-N, Stanley M, Garland SM. HPV prevention and control \u2013 the way forward. Prev Med. 2022;156:106960. https:\/\/doi.org\/10.1016\/j.ypmed.2022.106960.","journal-title":"Prev Med"},{"key":"2451_CR30","doi-asserted-by":"publisher","unstructured":"Yar\u0131c\u0131 F, Mammadov B. An analysis of the knowledge of adults aged between 18 and 45 on HPV along with their attitudes and beliefs about HPV vaccine: the Cyprus case. BMC Womens Health 2023 Feb 16;23(1):70. doi: https:\/\/doi.org\/10.1186\/s12905-023-02217-2.","DOI":"10.1186\/s12905-023-02217-2"},{"issue":"10167","key":"2451_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(18)32470-X.","journal-title":"Lancet"},{"issue":"20","key":"2451_CR32","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.3390\/ijerph192013176","volume":"19","author":"B Pecorino","year":"2022","unstructured":"Pecorino B, D\u2019Agate MG, Scibilia G, Scollo P, Giannini A, Di Donna MC, Chiantera V, Lagan\u00e0 AS. Evaluation of surgical outcomes of abdominal radical hysterectomy and total laparoscopic radical hysterectomy for cervical cancer: a retrospective analysis of data collected before the LACC trial. Int J Environ Res Public Health. 2022;19(20):13176. https:\/\/doi.org\/10.3390\/ijerph192013176.","journal-title":"Int J Environ Res Public Health"},{"issue":"18","key":"2451_CR33","doi-asserted-by":"publisher","first-page":"11641","DOI":"10.3390\/ijerph191811641","volume":"19","author":"G Bogani","year":"2022","unstructured":"Bogani G, Di Donato V, Scambia G, Raspagliesi F, Chiantera V, et al. Radical hysterectomy for early stage cervical cancer. Int J Environ Res Public Health. 2022;19(18):11641. https:\/\/doi.org\/10.3390\/ijerph191811641.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"2451_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/AOG.0000000000003952","volume":"136","author":"ES Smith","year":"2020","unstructured":"Smith ES, Moon AS, O\u2019Hanlon R, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Mueller JJ. Radical trachelectomy for the treatment of early-stage cervical cancer: a systematic review. Obstet Gynecol. 2020;136(3):533\u201342. https:\/\/doi.org\/10.1097\/AOG.0000000000003952.","journal-title":"Obstet Gynecol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02451-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02451-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02451-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T18:01:29Z","timestamp":1685815289000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02451-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2451"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02451-8","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,3]]},"assertion":[{"value":"24 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board at Near East University (Project No: YDU\/2022\/106\u20131607) and conformed to the ethics guidelines of the Declaration of Helsinki. Due to the nature of this retrospective study and the preserved anonymity of patients, a waiver of informed consent was obtained from Near East University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"297"}}